SPRC实时信号 | 通过Getagraph.com最大化利润

出售 120643 min ago

@ $3.99

发出时间: 6 Feb 2024 @ 22:45

回报率: -64.41%

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 04:00):

Stats
今日成交量	136 411
平均成交量	834 604
市值	3.48M
EPS	$0 ( 2023-08-07 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.00600 (0.42%)

音量相关性

長: 0.03 (neutral)

短: -0.37 (neutral)

Signal:(56.484) Neutral

SciSparc Ltd. 相关性

10 最正相关
MXIM	0.937
HYMC	0.83
LSBK	0.801

10 最负相关
IKNX	-0.851
APOP	-0.841
CMLF	-0.826
MAGS	-0.805
MOSY	-0.804

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

SciSparc Ltd. 相关性 - 货币/商品

0.34
( neutral )

0.40
( neutral )

0.00
( neutral )

-0.76
( moderate negative )

0.53
( weak )

SciSparc Ltd. 财务报表

Annual	2023
营收:	$2.88M
毛利润:	$2.20M (76.28 %)
EPS:	$-12.55

FY	2023
营收:	$2.88M
毛利润:	$2.20M (76.28 %)
EPS:	$-12.55

FY	2022
营收:	$1.35M
毛利润:	$1.03M (76.10 %)
EPS:	$-14.73

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.160

Financial Reports:

No articles found.

SciSparc Ltd.

SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in soft gel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to examine the potential role of SCI-210 for the treatment of status epilepticus; and The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.